539561 Stock Overview
A pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Remedium Lifecare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹6.19 |
| 52 Week High | ₹38.25 |
| 52 Week Low | ₹5.29 |
| Beta | -13.96 |
| 11 Month Change | -10.68% |
| 3 Month Change | -36.25% |
| 1 Year Change | -76.75% |
| 33 Year Change | 422.84% |
| 5 Year Change | 2,967.62% |
| Change since IPO | 5,402.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539561 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -6.8% | -1.8% | -1.8% |
| 1Y | -76.8% | 41.2% | 27.2% |
Return vs Industry: 539561 underperformed the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 539561 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| 539561 volatility | |
|---|---|
| 539561 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 539561 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 539561's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 7 | Adarsh Munjal | www.remlife.com |
Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. The company was formerly known as Roxy Exports Limited and changed its name to Remedium Lifecare Limited in November 2020.
Remedium Lifecare Limited Fundamentals Summary
| 539561 fundamental statistics | |
|---|---|
| Market cap | ₹2.50b |
| Earnings (TTM) | ₹241.05m |
| Revenue (TTM) | ₹33.44b |
10.4x
P/E Ratio0.1x
P/S RatioIs 539561 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539561 income statement (TTM) | |
|---|---|
| Revenue | ₹33.44b |
| Cost of Revenue | ₹33.15b |
| Gross Profit | ₹293.92m |
| Other Expenses | ₹52.87m |
| Earnings | ₹241.05m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 0.88% |
| Net Profit Margin | 0.72% |
| Debt/Equity Ratio | 395.4% |
How did 539561 perform over the long term?
See historical performance and comparison